Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey J Langer

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancerCorey J Langer, Silvia Novello, Keunchil Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
American Journal of Clinical Oncology|April 22, 2016
Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential TreatmentGenevieve Maquilan, Surbhi Grover, Eric Xanthopoulos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2018
Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung CancerSharyn I Katz, Mark Hammer, Stephen J Bagley, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety"Joshua M Bauml, Andrea Troxel, C Neill Epperson, et al.
Clinical Lung Cancer|February 12, 2017
The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion SynopsisMark A Socinski, Jamie E Chaft, Benjamin Levy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2010
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancerBenjamin Movsas, Corey J Langer, Helen J Ross, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancerCorey J Langer, Silvia Novello, Keunchil Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
American Journal of Clinical Oncology|April 22, 2016
Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential TreatmentGenevieve Maquilan, Surbhi Grover, Eric Xanthopoulos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2018
Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung CancerSharyn I Katz, Mark Hammer, Stephen J Bagley, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety"Joshua M Bauml, Andrea Troxel, C Neill Epperson, et al.
Clinical Lung Cancer|February 12, 2017
The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion SynopsisMark A Socinski, Jamie E Chaft, Benjamin Levy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2010
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancerBenjamin Movsas, Corey J Langer, Helen J Ross, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
Pageof 23